Literature DB >> 9347851

Perivascular and intralesional tissue necrosis after hepatic cryoablation: results in a porcine model.

S M Weber1, F T Lee, D O Chinn, T Warner, S G Chosy, D M Mahvi.   

Abstract

BACKGROUND: Cryosurgical ablation of malignant hepatic tumors is being increasingly used for definitive treatment of metastatic colorectal and primary hepatic tumors. The lack of tumor necrosis near vessels that results from inadequate freezing may contribute to local recurrence and thus limit the applications of this therapy. This study was designed to determine whether single-freeze cryoablation could cause necrosis of both the pervascular and intralesional hepatic parenchyma.
METHODS: Ten pigs were treated with one 15-minute cycle of cryoablation. Five additional animals were treated with overlapping cryolesions to simulate a double freeze. After 24 hours, animals underwent reoperation with portal vein cannulation and infusion of formalin. Serial sectioning and hematoxylin and eosin staining of cryolesions were performed.
RESULTS: Complete cell death was visualized within all cryolesions. There was no difference between once or twice-frozen tissue. Vessels within or adjacent to cryolesions showed necrosis of hepatic tissue up to the vessel wall. No sections revealed incomplete necrosis of perivascular hepatic parenchyma.
CONCLUSIONS: Single-freeze cryoablation results in necrosis of intralesional hepatic parenchyma without added benefit from repeat freezing. Complete necrosis of the perivascular tissue suggests that cryosurgical ablation can effectively cause necrosis immediately adjacent to vessels without concerns of incomplete ablation resulting from the heat sink effect.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9347851     DOI: 10.1016/s0039-6060(97)90082-9

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  16 in total

1.  Radiofrequency ablation of hepatic malignancies: is heat better than cold?

Authors:  D M Mahvi; F T Lee
Journal:  Ann Surg       Date:  1999-07       Impact factor: 12.969

Review 2.  Percutaneous Image-Guided Cryoablation in Vascular Anomalies.

Authors:  Raja Shaikh
Journal:  Semin Intervent Radiol       Date:  2017-09-11       Impact factor: 1.513

Review 3.  Thermal ablation of stage I non-small cell lung carcinoma.

Authors:  Carol A Ridge; Stephen B Solomon; Raymond H Thornton
Journal:  Semin Intervent Radiol       Date:  2014-06       Impact factor: 1.513

4.  Irreversible electroporation near the heart: ventricular arrhythmias can be prevented with ECG synchronization.

Authors:  Ajita Deodhar; Timm Dickfeld; Gordon W Single; William C Hamilton; Raymond H Thornton; Constantinos T Sofocleous; Majid Maybody; Mithat Gónen; Boris Rubinsky; Stephen B Solomon
Journal:  AJR Am J Roentgenol       Date:  2011-03       Impact factor: 3.959

5.  Percutaneous cryoablation of adrenal metastases: technical feasibility and safety.

Authors:  Hussein D Aoun; Peter J Littrup; Bashar Nahab; Michael Rizk; Matthew Prus; Julie Samantray; Donald Weaver; Ulka Vaishampayan; Edson Pontes
Journal:  Abdom Radiol (NY)       Date:  2021-02-04

Review 6.  Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective.

Authors:  Ronnie Tung-Ping Poon; Sheung-Tat Fan; Flora Hau-Fung Tsang; John Wong
Journal:  Ann Surg       Date:  2002-04       Impact factor: 12.969

7.  Rationale for the combination of cryoablation with surgical resection of hepatic tumors.

Authors:  C Cha; F T Lee; L F Rikkers; J E Niederhuber; B T Nguyen; D M Mahvi
Journal:  J Gastrointest Surg       Date:  2001 Mar-Apr       Impact factor: 3.452

8.  Soft-tissue cryoablation in diffuse locations: feasibility and intermediate term outcomes.

Authors:  Peter J Littrup; Hyun J Bang; Brandt P Currier; Dylan J Goodrich; Hussein D Aoun; Lance K Heilbrun; Barbara A Adam
Journal:  J Vasc Interv Radiol       Date:  2013-09-20       Impact factor: 3.464

Review 9.  Comparison of percutaneous ablation technologies in the treatment of malignant liver tumors.

Authors:  Hyeon Yu; Charles T Burke
Journal:  Semin Intervent Radiol       Date:  2014-06       Impact factor: 1.513

10.  Sorafenib combined with cryoablation to treat unresectable hepatocellular carcinoma.

Authors:  Hong Ni; Mao Yang; Zhi Guo; Ti Zhang
Journal:  Chin J Cancer Res       Date:  2011-09       Impact factor: 5.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.